Plus, William Blairâs memory âsupercycleâ winner, a stock Morgan Stanley says has âongoing execution issuesâ, Netflixâs new deal, the top IPOs of tomorrow, and more.
Jan 24, 2026
Apr 18, 2026
â˘
1 min read
Plus, a Permian Basin play that just got a 73% PT bump, a GPCR drug developer with 60% upside potential, and more...
Apr 11, 2026
2 min read
Plus, a precision oncology biotech with room to run, a CNS drug challenger with nearly $4B in projected peak sales, and more...
Apr 4, 2026
Plus, a top-1% analyst's highest-conviction AI infrastructure bet and the post-IPO software name Goldman says the market is missing out on.
